Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston
5
×
boston blog main
boston top stories
life sciences
national blog main
new york blog main
new york top stories
5
×
biotech
deals
national top stories
startups
clinical trials
fda
investing
san francisco blog main
san francisco top stories
abbott laboratories
adel malek
allopregnanolone
antisense oligonucleotide
aton partners
azacitidine
benzodiazepines
beta-thalassemia
biogen
biontech
blackstone group
blackstone life sciences
boehringer ingelheim
brexanolone
carl heilman
cerevasc
chris garabedian
clinical trial
columbia university
curevac
dacogen
dan levangie
david goldstein
decitabine
What
new
5
×
medicines
aims
called
drugs
research
absorb
address
approach
approved
backed
based
bets
bio
biotech
body
brain
brexanolone
builds
cancer
cause
ceo
cerevasc
comes
companies
cut
date
deal
debuts
depression
devastating
developing
device
disorder
drain
drug
effective
enticed
epigenetic
epigenetics
Language
unset
Current search:
new
×
boston
×
" new york top stories "
×
@xconomy.com
4 years ago
CereVasc Lands $44M for New Medical Device to Drain “Water on the Brain”
@xconomy.com
4 years ago
Backed by $100M, Praxis Aims to Turn Epilepsy Research Into New Neuro Drugs
@xconomy.com
4 years ago
Flagship’s Omega Aims to Take Epigenetic Drugs a Step Further
@xconomy.com
5 years ago
FDA OKs Depression Drug For New Moms: Fast Relief But Tough to Take
@xconomy.com
6 years ago
With $45M Translate Bio Deal, Sanofi Bets Again on mRNA Vaccines
